Effect of tibolone treatment on intima-media thickness and the resistive indices of the carotid arteries

Fertility and Sterility

Volumn 79, Issue 2, 2003, Pages 268-273

  Erenus, Mithat ^a,b   Ilhan, A Hakan ^a   Elter, Koray ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b NONE   (Turkey)

Author keywords

Carotid arteries; Intima media thickness; Tibolone

Indexed keywords

TIBOLONE;

ADULT; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CLINICAL TRIAL; COMMON CAROTID ARTERY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ECHOGRAPHY; EXTERNAL CAROTID ARTERY; FEMALE; HUMAN; INTERNAL CAROTID ARTERY; MENOPAUSAL SYNDROME; PATIENT SELECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; THICKNESS; VASCULAR RESISTANCE; VERTEBRAL ARTERY;

ADULT; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; CAROTID ARTERIES; ESTROGEN RECEPTOR MODULATORS; FEMALE; HUMANS; MIDDLE AGED; NORPREGNENES; POSTMENOPAUSE; PROSPECTIVE STUDIES; TUNICA INTIMA; TUNICA MEDIA; VASCULAR RESISTANCE;

EID: 0037307934     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(02)04580-6     Document Type: Article

References (47)

1. Seed M. Postmenopausal hormone replacement therapy, coronary heart disease and plasma lipoproteins. Drugs. 47:(Suppl 2):1994;25-34.
2. Zandberg P., Peters J.L.M., Demacker P.N., de Reeder E.G., Smit M.J., Meuleman D.G. Comparison of the antiatherosclerotic effect of tibolone with that of estradiol and ethinyl estradiol in cholesterol-fed, ovariectomized rabbits. Menopause. 8:2001;96-105.
3. Barrett-Connor E. The menopause, hormone replacement, and cardiovascular disease the epidemiologic evidence . Maturitas. 23:1996;227-234.
4. Kafonek S.D. Postmenopausal hormone replacement therapy and cardiovascular risk reduction. Drugs. 47:(Suppl 2):1994;16-24.
5. Barrett-Connor E., Bush T.L. Estrogen and coronary heart disease in women. JAMA. 265:1991;1861-1867.
6. Bush T.L., Barrett-Connor E., Cowan L.D., Criqui M.H., Wallace R.B., Suchindran C.M., et al. Cardiovascular mortality and noncontraceptive use of estrogen in women results from the Lipid Research Clinics Program Follow-up Study . Circulation. 75:1987;1102-1109.
7. Mendelsohn M.E., Karas R.H. Estrogen and the blood vessel wall. Curr Opin Cardiol. 9:1994;619-626.
8. Vidovic I.P., Demarin V., Grubisic G., Kuna K., Huzjan A.L. Carotid artery intima thickness and flow velocity after discontinuation of hormone replacement therapy in postmenopausal women follow-up study . Croat Med J. 42:2001;54-57.
9. Tremollieres F.A., Cigagna F., Alquier C., Cauneille C., Pouilles J., Ribot C. Effects of hormone replacement therapy on age-related increase in carotid artery intima-media thickness in postmenopausal women. Atherosclerosis. 153:2000;81-88.
10. Westendorp I.C., in 't Veld B.A., Bots M.L., Akkerhuis J.M., Hofman A., Grobbee D.E., et al. Hormone replacement therapy and intima-media thickness of the common carotid artery the Rotterdam study . Stroke. 30:1999;2562-2567.
11. Signorelli S.S., Salvatore S., Luigi D., Pia C.M., Giuseppe P., Sarina C. Serum lipids and lipoproteins and carotid artery wall intima-media thickness in a population of menopausal women. Menopause. 6:1999;230-232.
12. Griewing B., Romer T., Spitzer C., Ludemann J., Gunther A., Kessler C. Hormone replacement therapy in postmenopausal women carotid intima-media thickness and 3-D volumetric plaque quantification . Maturitas. 32:1999;33-40.
13. Anderson H.V. Estrogen therapy, atherosclerosis, and clinical cardiovascular events. Circulation. 94:1996;1809-1811.
14. Muscat Baron Y., Brincat M., Galea R. Carotid artery wall thickness in women treated with hormone replacement therapy. Maturitas. 27:1997;47-53.
15. Moore R.A. Livial a review of clinical studies . Br J Obstet Gynaecol. 106:(Suppl 19):1999;1-21.
16. O'Leary D.H., Polak J.F., Kronmal R.A., Kittner S.J., Bond M.G., Wolfson S.K. Jr., et al. Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. The CHS Collaborative Research Group. Stroke. 23:1992;1752-1760.
17. Allan P.L., Mowbray P.I., Lee A.J., Fowkes F.G. Relationship between carotid intima-media thickness and symptomatic and asymptomatic peripheral arterial disease. The Edinburgh Artery Study. Stroke. 28:1997;348-353.
18. Blankenhorn D.H., Rooney J.A., Curry P.J. Noninvasive assessment of atherosclerosis. Prog Cardiovasc Dis. 26:1984;295-307.
19. Pignoli P., Tremoli E., Poli A., Oreste P., Paoletti R. Intimal plus medial thickness of the arterial wall a direct measurement with ultrasound imaging . Circulation. 74:1986;1399-1406.
20. Howard G., Sharrett A.R., Heiss G., Evans G.W., Chambless L.E., Riley W.A., et al. Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC Investigators. Stroke. 24:1993;1297-1304.
21. Salonen R., Salonen J.T. Determinants of carotid intima-media thickness a population-based ultrasonography study in Eastern Finnish men . J Intern Med. 229:1991;225-231.
22. Poli A., Tremoli E., Colombo A., Sirtori M., Pignoli P., Paoletti R. Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients a new model for the quantitation and follow-up of preclinical atherosclerosis in living human subjects . Atherosclerosis. 70:1988;253-261.
23. Mannami T., Konishi M., Baba S., Nishi N., Terao A. Prevalence of asymptomatic carotid atherosclerotic lesions detected by high-resolution ultrasonography and its relation to cardiovascular risk factors in the general population of a Japanese city the Suita study . Stroke. 28:1997;518-525.
24. Bots M.L., Breslau P.J., Briet E., de Bruyn A.M., van Vliet H.H., van den Ouweland F.A., et al. Cardiovascular determinants of carotid artery disease the Rotterdam Elderly Study . Hypertension. 19:1992;717-720.
25. Burke G.L., Evans G.W., Riley W.A., Sharrett A.R., Howard G., Barnes R.W., et al. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study. Stroke. 26:1995;386-391.
26. Frauchiger B., Schmid H.P., Roedel C., Moosmann P., Staub D. Comparison of carotid arterial resistive indices with intima-media thickness as sonographic markers of atherosclerosis. Stroke. 32:2001;836-841.
27. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 280:1998;605-613.
28. Herrington D.M., Reboussin D.M., Brosnihan K.B., Sharp P.C., Shumaker S.A., Snyder T.E., et al. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med. 343:2000;522-529.
29. Jonas H.A., Kronmal R.A., Psaty B.M., Manolio T.A., Meilahn E.N., Tell G.S., et al. Current estrogen-progestin and estrogen replacement therapy in elderly women association with carotid atherosclerosis. CHS Collaborative Research Group. Cardiovascular Health Study . Ann Epidemiol. 6:1996;314-323.
30. McGrath B.P., Liang Y.L., Teede H., Shiel L.M., Cameron J.D., Dart A. Age-related deterioration in arterial structure and function in postmenopausal women impact of hormone replacement therapy . Arterioscler Thromb Vasc Biol. 18:1998;1149-1156.
31. Punnonen R., Jokela H., Heinonen P.K., Aine R., Dastidar P. Hormone replacement therapy and atherosclerosis. J Reprod Med. 40:1995;267-272.
32. Espeland M.A., Applegate W., Furberg C.D., Lefkowitz D., Rice L., Hunninghake D. Estrogen replacement therapy and progression of intimal-medial thickness in the carotid arteries of postmenopausal women. ACAPS Investigators. Asymptomatic Carotid Atherosclerosis Progression Study. Am J Epidemiol. 142:1995;1011-1019.
33. Albertazzi P., Di Micco R., Zanardi E. Tibolone a review . Maturitas. 30:1998;295-305.
34. Rymer J.M. The effects of tibolone. Gynecol Endocrinol. 12:1998;213-220.
35. Hardiman P., Nihoyannopoulos P., Kicovic P., Ginsburg J. Cardiovascular effects of Org OD 14 - a new steroidal therapy for climacteric symptoms. Maturitas. 13:1991;235-242.
36. Lloyd G.W., Patel N.R., McGing E.A., Cooper A.F., Kamalvand K., Jackson G. Acute effects of hormone replacement with tibolone on myocardial ischaemia in women with angina. Int J Clin Pract. 52:1998;155-157.
37. Lehmann E.D., Hopkins K.D., Parker J.R., Turay R.C., Rymer J., Fogelman I., et al. Aortic distensibility in post-menopausal women receiving Tibolone. Br J Radiol. 67:1994;701-705.
38. Clarkson T.B., Anthony M.S., Wagner J.D. A comparison of tibolone and conjugated equine estrogens effects on coronary artery atherosclerosis and bone density of postmenopausal monkeys. J Clin Endocrinol Metab. 86:2001;5396-5404.
39. O'Leary D.H., Polak J.F., Kronmal R.A., Manolio T.A., Burke G.L., Wolfson S.K. Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 340:1999;14-22.
40. Espeland M.A., Applegate W., Furberg C.D., Lefkowitz D., Rice L., Hunninghake D. Estrogen replacement therapy and progression of intimal-medial thickness in the carotid arteries of postmenopausal women. ACAPS Investigators. Asymptomatic Carotid Atherosclerosis Progression Study. Am J Epidemiol. 142:1995;1011-1019.
41. Muscat Baron Y., Galea R., Brincat M. Carotid artery wall changes in estrogen-treated and -untreated postmenopausal women. Obstet Gynecol. 91:1998;982-986.
42. Nabulsi A.A., Folsom A.R., Szklo M., White A., Higgins M., Heiss G. No association of menopause and hormone replacement therapy with carotid artery intima-media thickness. Circulation. 94:1996;1857-1863.
43. Hashimoto M., Miyao M., Akishita M., Hosoi T., Toba K., Kozaki K., et al. Effects of long-term and reduced-dose hormone replacement therapy on endothelial function and intima-media thickness in postmenopausal women. Menopause. 9:2002;58-64.
44. Pontremoli R., Viazzi F., Martinoli C., Ravera M., Nicolella C., Berruti V., et al. Increased renal resistive index in patients with essential hypertension a marker of target organ damage . Nephrol Dial Transp. 14:1999;360-365.
45. Ishimura E., Nishizawa Y., Kawagishi T., Okuno Y., Kogawa K., Fukumoto S., et al. Intrarenal hemodynamic abnormalities in diabetic nephropathy measured by duplex Doppler sonography. Kidney Int. 51:1997;1920-1927.
46. Frauchiger B., Nussbaumer P., Hugentobler M., Staub D. Duplex sonographic registration of age and diabetes-related loss of renal vasodilatory response to nitroglycerine. Nephrol Dial Transplant. 15:2000;827-832.
47. Ginsburg J., Prelevic G.M. Tibolone and the serum lipid/lipoprotein profile does this have a role in cardiovascular protection in postmenopausal women? Menopause. 6:1999;87-89.